Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

Bibliographic Details
Main Authors: Hannouf, Malek B, Xie, Bin, Brackstone, Muriel, Zaric, Gregory S
Format: Online
Language:English
Published: BioMed Central 2012
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488327/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488327/

Similar Items